Cleared Traditional

K010424 - NEXAN SYSTEM, MODEL NX-301

K010424 is an FDA 510(k) clearance for NEXAN SYSTEM, manufactured by Nexan, Ltd.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 203-day FDA review.

K010424 · Nexan, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2001
Decision
203d
Days
Class 2
Risk

K010424 is an FDA 510(k) clearance for the NEXAN SYSTEM, MODEL NX-301. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Nexan, Ltd. (Rockville, US). The FDA issued a Cleared decision on September 4, 2001 after a review of 203 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Nexan, Ltd. devices

FDA 510(k) Submission Details - K010424

510(k) Number K010424 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 2001
Decision Date September 04, 2001
Days to Decision 203 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
78d slower than avg
Panel avg: 125d · This submission: 203d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 249
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K010424.
DINAMAP PRO SERIES MONITOR, MODELS 110, 210, 310, 410
K020022 · Ge Medical Systems Information Technologies · Feb 2002
M2376A DEVICELINK SYSTEM, MODEL M2376A
K014181 · Philips Medical Systems, Inc. · Jan 2002
MODIFICATION TO M2376A DEVICELINK SYSTEM
K013470 · Philips Medical Systems, Inc. · Nov 2001
8100/8500 VITAL SIGNS MONITOR
K012059 · Criticare Systems, Inc. · Aug 2001
MODIFICATION TO DEVICE LINK SYSTEM, MODEL M2376A
K012094 · Agilent Technologies, Inc. · Jul 2001
M2376A DEVICELINK SYSTEM, MODEL M2376A
K011578 · Agilent Technologies, Inc. · Jun 2001